BACTERIOPHAGE THERAPY AS AN ALTERNATIVE TO ANTIBIOTICS

The emergence of multidrug-resistant (MDR) bacteria has become a global health crisis, limiting
the effectiveness of conventional antibiotics. Bacteriophage therapy,the use of viruses that
specifically infect and lyse bacteria, is re-emerging as a promising alternative strategy.To explore
the therapeutic potential of bacteriophages in combating antibiotic resistance and highlight their
clinical applications.Bacteriophages exhibit a high degree of host specificity, targeting only
pathogenic bacteria without disturbing the normal microbiota. Unlike antibiotics, they can selfreplicate at the site of infection, enhancing efficacy. Phage cocktails are being investigated to
broaden the antibacterial spectrum and prevent resistance development. Recent clinical trials and
case studies demonstrate successful use of phage therapy in treating chronic infections, including
Pseudomonas aeruginosa andStaphylococcus aureus. Challenges remain, such as phage resistance,
regulatory approval, and large-scale production.
Bacteriophage therapy represents a novel, targeted, and potentially safer approach to manage drugresistant bacterial infections. Further research and clinical integration may establish phages as a
valuable adjunct or alternative to antibiotics.
Keywords: Bacteriophage therapy, Antibiotic resistance, Phage cocktails, Multidrug-resistant
bacteria, Alternative therapeutics.